Create a free account or log in.
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (former working name Mangoral) and Oncoral – in clinical development.
About Orviglance (Mangoral)
Orviglance* (manganese chloride tetrahydrate) is a novel oral contrast agent for MR-imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with reduced kidney function.
About Oncoral
Oncoral is a novel oral irinotecan tablet in development. Irinotecan is a chemotherapy with established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily tablet with the potential to offer better patient outcomes with improved safety following a daily tablet treatment compared to intravenous high-dose infusions at the hospital.
Worldwide
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
| Person (Position) | Type | Volume | Price | Date |
|---|---|---|---|---|
|
◆
Peter Benson
(Other)
|
Other | SEK 107,500.00 | SEK 2.15 | 15.04.25 |
|
◆
Peter Benson
(Other)
|
Other | SEK 46,629.20 | SEK 2.15 | 15.04.25 |
|
◆
Peter Benson
(Other)
|
Other | SEK 44,014.80 | SEK 2.15 | 15.04.25 |
|
◆
Peter Benson
(Other)
|
Other | SEK 13,226.80 | SEK 2.15 | 15.04.25 |
|
↓
KIBEGEON
(Other)
|
Sell | SEK 150,917.63 | SEK 0.16 | 03.09.24 |
|
↓
Niels Mengel
(Other)
|
Sell | SEK 17,815.28 | SEK 0.13 | 03.09.24 |
|
↓
Niels Mengel
(Other)
|
Sell | SEK 17,815.28 | SEK 0.13 | 26.08.24 |
|
↑
Peter Benson
(Other)
|
Buy | SEK 46,191.45 | SEK 8.79 | 09.02.24 |
|
↑
Julie Brogren
(Other)
|
Buy | SEK 169,500.00 | SEK 5.65 | 08.01.24 |
|
↑
Peter Benson
(Other)
|
Buy | SEK 58,500.00 | SEK 5.85 | 08.01.24 |
5493002YR9VCJJPWYN08
IKM
Sector
Health Care
Country
Spain
ISIN
Founded
1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.
2CUREX
Sector
Health Care
Country
Sweden
ISIN
SE0010468124
Founded
2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABERA
Sector
Health Care
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …